Evidence map›Paper›PMID 37764056›Full record

ArticleMicroorganisms2023

Invasive Disease Due to

Chen Stein-Zamir, Hanna Shoob, Nitza Abramson, Lea Valinsky, Joseph Jaffe, David Maimoun, Sharon Amit, Maya Davidovich-Cohen

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Is meningococcal B vaccination needed in the post-COVID-19 world?Biomedica : revista del Instituto Nacional de Salud · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chen Stein-ZamirJerusalem District Health Office, Ministry of Health, 86 Jaffa Road, Jerusalem 9434124, Israel.ORCID 0000-0002-8847-7510
Hanna ShoobJerusalem District Health Office, Ministry of Health, 86 Jaffa Road, Jerusalem 9434124, Israel.
Nitza AbramsonJerusalem District Health Office, Ministry of Health, 86 Jaffa Road, Jerusalem 9434124, Israel.
Lea ValinskyPublic Health Laboratories Jerusalem, Public Health Services, Ministry of Health, Jerusalem 9546208, Israel.
Joseph JaffePublic Health Laboratories Jerusalem, Public Health Services, Ministry of Health, Jerusalem 9546208, Israel.
David MaimounPublic Health Laboratories Jerusalem, Public Health Services, Ministry of Health, Jerusalem 9546208, Israel.
Sharon AmitClinical Microbiology, Sheba Medical Center, Ramat Gan 5266202, Israel.
Maya Davidovich-CohenPublic Health Laboratories Jerusalem, Public Health Services, Ministry of Health, Jerusalem 9546208, Israel.
Israel Ministry of Health · ILHebrew University of Jerusalem · ILSheba Medical Center · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) is a devastating disease with significant mortality and long-term morbidity. The COVID-19 pandemic and containment measures have affected the epidemiology of infectious pathogens. This study's aim was to assess IMD trends in Israel prior to and during the COVID-19 pandemic. The

Indexed as

clonesinvasive meningococcal diseasemolecular epidemiologyNeisseria meningitidis

Identifiers

PMID37764056
PMCPMC10537818
OpenAlexW4386307168

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.